647 related articles for article (PubMed ID: 29405289)
1. Role of artificial intelligence in the care of patients with nonsmall cell lung cancer.
Rabbani M; Kanevsky J; Kafi K; Chandelier F; Giles FJ
Eur J Clin Invest; 2018 Apr; 48(4):. PubMed ID: 29405289
[TBL] [Abstract][Full Text] [Related]
2. [Study Progress of Radiomics in Precision Medicine for Lung Cancer].
Shi Z; Zhang X; Jiang T
Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):385-388. PubMed ID: 31196373
[TBL] [Abstract][Full Text] [Related]
3. Radiomics and artificial intelligence for precision medicine in lung cancer treatment.
Chen M; Copley SJ; Viola P; Lu H; Aboagye EO
Semin Cancer Biol; 2023 Aug; 93():97-113. PubMed ID: 37211292
[TBL] [Abstract][Full Text] [Related]
4. Current clinical immunotherapy targets in advanced nonsmall cell lung cancer (NSCLC).
McCarthy F; Roshani R; Steele J; Hagemann T
J Leukoc Biol; 2013 Dec; 94(6):1201-6. PubMed ID: 23695306
[TBL] [Abstract][Full Text] [Related]
5. Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis.
Yu Y; He J
Front Med; 2013 Jun; 7(2):157-71. PubMed ID: 23681892
[TBL] [Abstract][Full Text] [Related]
6. Artificial Intelligence Enhances NSCLC Care by Predicting Treatment Outcomes, Validating Neoadjuvant Therapies, and Improving Precision.
Ishikawa S
J Thorac Oncol; 2024 May; 19(5):666-667. PubMed ID: 38719421
[No Abstract] [Full Text] [Related]
7. New Machine Learning Applications to Accelerate Personalized Medicine in Breast Cancer: Rise of the Support Vector Machines.
Ozer ME; Sarica PO; Arga KY
OMICS; 2020 May; 24(5):241-246. PubMed ID: 32228365
[TBL] [Abstract][Full Text] [Related]
8. Management of non-small cell lung cancer in the era of personalized medicine.
Rocco G; Morabito A; Leone A; Muto P; Fiore F; Budillon A
Int J Biochem Cell Biol; 2016 Sep; 78():173-179. PubMed ID: 27425397
[TBL] [Abstract][Full Text] [Related]
9. Artificial Intelligence in Precision Cardiovascular Medicine.
Krittanawong C; Zhang H; Wang Z; Aydar M; Kitai T
J Am Coll Cardiol; 2017 May; 69(21):2657-2664. PubMed ID: 28545640
[TBL] [Abstract][Full Text] [Related]
10. Machine Learning-Assisted Recurrence Prediction for Patients With Early-Stage Non-Small-Cell Lung Cancer.
Janik A; Torrente M; Costabello L; Calvo V; Walsh B; Camps C; Mohamed SK; Ortega AL; Nováček V; Massutí B; Minervini P; Campelo MRG; Del Barco E; Bosch-Barrera J; Menasalvas E; Timilsina M; Provencio M
JCO Clin Cancer Inform; 2023 Jul; 7():e2200062. PubMed ID: 37428988
[TBL] [Abstract][Full Text] [Related]
11. Applications of Artificial Intelligence in Lung Pathology.
Hartman DJ
Surg Pathol Clin; 2024 Jun; 17(2):321-328. PubMed ID: 38692814
[TBL] [Abstract][Full Text] [Related]
12. Future artificial intelligence tools and perspectives in medicine.
Chaddad A; Katib Y; Hassan L
Curr Opin Urol; 2021 Jul; 31(4):371-377. PubMed ID: 33927099
[TBL] [Abstract][Full Text] [Related]
13. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
[TBL] [Abstract][Full Text] [Related]
14. Artificial intelligence in lung cancer diagnosis and prognosis: Current application and future perspective.
Huang S; Yang J; Shen N; Xu Q; Zhao Q
Semin Cancer Biol; 2023 Feb; 89():30-37. PubMed ID: 36682439
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence in clinical applications for lung cancer: diagnosis, treatment and prognosis.
Pei Q; Luo Y; Chen Y; Li J; Xie D; Ye T
Clin Chem Lab Med; 2022 Nov; 60(12):1974-1983. PubMed ID: 35771735
[TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence: A joint narrative on potential use in pediatric stem and immune cell therapies and regenerative medicine.
Sniecinski I; Seghatchian J
Transfus Apher Sci; 2018 Jun; 57(3):422-424. PubMed ID: 29784537
[TBL] [Abstract][Full Text] [Related]
17. Looking back and to the future: Are we improving 'cure' in non-small cell lung cancer?
Walder D; O'Brien M
Eur J Cancer; 2017 Apr; 75():192-194. PubMed ID: 28236771
[TBL] [Abstract][Full Text] [Related]
18. Artificial intelligence: opportunities in lung cancer.
Zhang K; Chen K
Curr Opin Oncol; 2022 Jan; 34(1):44-53. PubMed ID: 34636351
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence with multi-functional machine learning platform development for better healthcare and precision medicine.
Ahmed Z; Mohamed K; Zeeshan S; Dong X
Database (Oxford); 2020 Jan; 2020():. PubMed ID: 32185396
[TBL] [Abstract][Full Text] [Related]
20. The value of nodal information in predicting lung cancer relapse using 4DPET/4DCT.
Li H; Becker N; Raman S; Chan TC; Bissonnette JP
Med Phys; 2015 Aug; 42(8):4727-33. PubMed ID: 26233200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
